Inspira Technologies OXY B.H.N. Ltd. (NASDAQ:IINN – Get Free Report) was the target of a large growth in short interest in December. As of December 31st, there was short interest totaling 262,537 shares, a growth of 34.0% from the December 15th total of 195,948 shares. Based on an average trading volume of 149,033 shares, the days-to-cover ratio is currently 1.8 days. Based on an average trading volume of 149,033 shares, the days-to-cover ratio is currently 1.8 days.
Analyst Ratings Changes
Several brokerages recently issued reports on IINN. Wall Street Zen raised Inspira Technologies OXY B.H.N. from a “sell” rating to a “hold” rating in a report on Sunday, October 26th. Weiss Ratings restated a “sell (d-)” rating on shares of Inspira Technologies OXY B.H.N. in a research report on Monday, December 29th. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $2.00.
View Our Latest Report on Inspira Technologies OXY B.H.N.
Institutional Trading of Inspira Technologies OXY B.H.N.
Inspira Technologies OXY B.H.N. Price Performance
IINN stock traded down $0.01 on Friday, reaching $0.88. The company had a trading volume of 142,520 shares, compared to its average volume of 168,483. The company’s fifty day moving average is $1.00 and its 200 day moving average is $1.13. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.15 and a quick ratio of 0.90. Inspira Technologies OXY B.H.N. has a 1 year low of $0.40 and a 1 year high of $1.65.
Inspira Technologies OXY B.H.N. Company Profile
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.
Read More
- Five stocks we like better than Inspira Technologies OXY B.H.N.
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for Inspira Technologies OXY B.H.N. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspira Technologies OXY B.H.N. and related companies with MarketBeat.com's FREE daily email newsletter.
